DACTYLIS GLOMERATA POLLEN: 28 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
28
Total FAERS Reports
0
Deaths Reported
2
Hospitalizations
28
As Primary/Secondary Suspect
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20160824 · Latest Report: 20231025
What Are the Most Common DACTYLIS GLOMERATA POLLEN Side Effects?
#1 Most Reported
Throat irritation
8 reports (28.6%)
#2 Most Reported
Anaphylactic reaction
8 reports (28.6%)
#3 Most Reported
Cough
7 reports (25.0%)
All DACTYLIS GLOMERATA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Anaphylactic reaction | 8 | 28.6% | 0 | 0 |
| Throat irritation | 8 | 28.6% | 0 | 0 |
| Cough | 7 | 25.0% | 0 | 0 |
| Dyspnoea | 6 | 21.4% | 0 | 2 |
| Pruritus | 6 | 21.4% | 0 | 0 |
| Eye pruritus | 5 | 17.9% | 0 | 0 |
| False negative investigation result | 5 | 17.9% | 0 | 1 |
| Rhinorrhoea | 5 | 17.9% | 0 | 0 |
Who Reports DACTYLIS GLOMERATA POLLEN Side Effects? Age & Gender Data
Gender: 63.6% female, 36.4% male. Average age: 37.4 years. Most reports from: US. View detailed demographics →
Is DACTYLIS GLOMERATA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 4 | 0 | 0 |
| 2017 | 4 | 0 | 0 |
| 2018 | 5 | 0 | 1 |
| 2021 | 2 | 0 | 0 |
| 2022 | 7 | 0 | 1 |
| 2023 | 2 | 0 | 0 |
What Is DACTYLIS GLOMERATA POLLEN Used For?
| Indication | Reports |
|---|---|
| Skin test | 5 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for DACTYLIS GLOMERATA POLLEN
Official prescribing information from the FDA-approved drug label.